Buerger Disease
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease (NCT05698979) | University Hospital, Toulouse | 2027-01-01 |
| Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) (NCT02501018) | Lisata Therapeutics, Inc. | 2017-11-01 |
| TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation (NCT00145262) | Nagoya University | 2003-08-01 |
Track Buerger Disease automatically
Every clearance here is in the API, with alerts when new ones post.